Ecstasy could bring joy to cancer sufferers

DERIVATIVES of the party drug ecstasy could be useful to treat haematological malignancies, researchers say.

Scientists at the University of Birmingham, in the UK, say modified forms of MDMA – the main active ingredient of ecstasy – boosted its ability to destroy carcinogenic cells by 100-fold.

This follows research six years ago showing that cancers affecting white blood cells appear to respond to certain psychotropic drugs, including weight loss pills, SSRIs and amphetamine derivatives such as MDMA.

Their latest research was paving the way to human trials of MDMA derivatives as therapeutics for